Correlation Engine 2.0
Clear Search sequence regions


  • ALB (1)
  • apoptosis (1)
  • cellular (1)
  • cisplatin (3)
  • hepatocellular carcinoma (7)
  • MAGEA3 (7)
  • MDR- 1 (1)
  • MRP2 (1)
  • MRP3 (1)
  • plasmids (1)
  • poor prognosis (2)
  • rna (2)
  • Sizes of these terms reflect their relevance to your search.

    Hepatocellular carcinoma (HCC) is a prevalent malignancy characterized by aggressiveness and poor prognosis; however, the molecular mechanism remains to be fully identified. Based on the analysis of The Cancer Genome Atlas (TCGA) database, melanoma-associated antigen A3 (MAGEA3) and long non-coding RNA (lncRNA) LINC01234 were upregulated in HCC and associated with poor prognosis of HCC. We investigated the mechanism of how MAGEA3 and LINC01234 influenced HCC cellular functions and cisplatin resistance. MAGEA3 depletion inhibited proliferation, invasion, and cisplatin resistance of HepG2 cells and Huh7 cells in vitro, reduced resistance-associated protein 2 (MRP2), MRP3, and multidrug resistance protein 1 (MDR-1) expression, and elevated ALB expression. RNA pull-down and RIP assays identified the binding of LINC01234 and MAGEA3 to microRNA-31-5p (miR-31-5p). LINC01234 could restore MAGEA3 expression by binding to miR-31-5p. Furthermore, we delivered plasmids into HepG2 cells and Huh7 cells to alter the expression of LINC01234 and miR-31-5p. When miR-31-5p was downregulated, the proliferation and invasion of HepG2 cells and Huh7 cells were enhanced and the cisplatin-induced apoptosis was inhibited, while LINC01234 knockdown could diminish the effects caused by miR-31-5p depletion. In summary, these data highlight the vital role of MAGEA3/LINC01234/miR-31-5p axis in the HCC progression and chemoresistance of HCC cells. Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

    Citation

    Yunhao Chen, Hui Zhao, Haibo Li, Xiao Feng, Hui Tang, Chunhui Qiu, Jianwen Zhang, Binsheng Fu. LINC01234/MicroRNA-31-5p/MAGEA3 Axis Mediates the Proliferation and Chemoresistance of Hepatocellular Carcinoma Cells. Molecular therapy. Nucleic acids. 2020 Mar 06;19:168-178


    PMID: 31838274

    View Full Text